Treatment with the studied drug:~Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg~Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 5 mg~Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 10 mg This is non-interventional study that is observational by its nature. Therefore there will be no any assignments of subjects to a particular therapeutic strategies defined by this protocol. Decision to treat a patient with SPC of amlodipine/ atorvastatin/ perindopril should be at the descretion of a treating investigator and made in accordance to local standards and protocols.
This is a multi-centre, observational, ambispective study, which will retrospectively and prospectively collect clinical and socio-demographic data from medical records of patients with HTN and dyslipidemia initiated with SPC of amlodipine/atorvastatin/perindopril in real clinical settings.~A total of 80 general practitioners and outpatient cardiologists will participate in this non-interventional study 400 patients should be included in the study.